Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference Pharmaceutical Investing
Knight Therapeutics and Helsinn Healthcare SA Enter into Exclusive License, Distribution, and Supply Agreement for Akynzeo® and Aloxi® Pharmaceutical Investing
Knight to Present at the 2022 RBC Capital Markets Global Healthcare Conference in New York City Pharmaceutical Investing
Abbott and Women as One Partner to Help More Underrepresented Physicians Lead Clinical Trials Pharmaceutical Investing
Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company Pharmaceutical Investing
Bausch Health And Bausch + Lomb Corporation Announce Closing Of Initial Public Offering Of Bausch + Lomb And Related Debt Transactions Pharmaceutical Investing
RNA 9000 Purity and Integrity Kit Allows for Critical High-Resolution Analysis for mRNA Therapeutics Medical Device Investing
Premier Health of America: Modernizing Healthcare Staffing with Automated, On-Demand Services Medical Device Investing